A new study published by the peer-reviewed Phytomedicine reports that cannabidiol (CBD) significantly reduced cognitive impairment following traumatic brain injury (TBI) by protecting neurons from oxidative stress and programmed cell death. The research was conducted by scientists from Shengjing Hospital of China Medical University and identifies a previously unrecognized molecular pathway through which CBD exerts its neuroprotective effects.
Cognitive decline is one of the most persistent and difficult complications of TBI, with few effective treatments available. While CBD is known for its antioxidant and anti-inflammatory properties, its role in post-TBI cognitive impairment has remained unclear. In this study, researchers examined whether CBD could protect neurons and preserve cognitive function after brain injury, and if so, how it works at the molecular level.
Using both cell-based oxidative stress models and a controlled cortical impact model of TBI in animals, the researchers found that CBD consistently reduced markers of neuronal oxidative stress and apoptosis. Neurons treated with CBD showed improved survival, lower levels of oxidative damage, and reduced activation of pro-apoptotic signaling pathways compared to untreated controls.
At the mechanistic level, the study identified a novel SET/PP2A/Akt signaling axis as central to CBD’s effects. The researchers found that CBD directly binds to the SET protein, triggering structural changes that keep SET localized in the cytoplasm rather than the nucleus. This shift suppresses the activity of PP2A, a phosphatase involved in regulating cell survival pathways, which in turn activates Akt signaling. Activation of Akt is associated with enhanced neuronal survival and resistance to oxidative stress.
Advanced techniques including RNA sequencing, protein interaction assays, molecular dynamics simulations, and cellular thermal shift analysis were used to confirm this mechanism. Together, the data show that CBD interrupts oxidative and apoptotic cascades at multiple levels, ultimately supporting neuronal integrity after injury.
The findings suggest that CBD may represent a promising therapeutic approach for treating cognitive impairment following traumatic brain injury, while also highlighting the SET/PP2A/Akt pathway as a potential drug target for future neuroprotective treatments.
More articles from The Marijuana Herald can be found below.
